West China Hospital Gastroenterology: Endoscopy, IBD and Pancreatobiliary Teams

What the department is and how it is organised

West China Hospital's gastroenterology group dates from 1956 and became an independent department in 1986. It was designated an education key discipline in 2007 and a clinical key specialty in 2010. Those designations describe institutional history and standing; they do not tell you which team should see a particular patient.

The department's own overview lists liver disease, pancreatobiliary disease, inflammatory bowel disease, gastrointestinal bleeding, and endoscopic minimally invasive and interventional digestive work among its directions. It also describes an endoscopy service, a peptide laboratory, collaboration on gastrointestinal tumours, an IBD laboratory, and a role in standardised Helicobacter pylori care. Read that as a map of where expertise sits, not as a promise that every service is open to every overseas patient.

The department placed sixth in the Fudan 2023 national specialty reputation list. This historical reference concerns the department, not a current ranking of its liver, pancreatobiliary, IBD or endoscopy programs. Those clinical directions provide a more specific starting point for identifying the assessment an overseas patient actually wants.

The clinical directions that matter for referral

Liver and pancreatobiliary disease are separate documented directions. An enquiry can state whether the unresolved question concerns an established liver diagnosis, a bile-duct or pancreatic condition, or a proposed intervention. Ask which clinical team would review that question and which existing reports would help it understand the previous assessment. A department's range does not select a procedure for the individual.

Inflammatory bowel disease has a distinct laboratory and clinical direction in the department. For a patient who has already received treatment, a useful question is whether the requested opinion concerns the diagnosis, a prior treatment plan or the next review. Hu Renwei's clinical profile provides a named contributor whose work includes IBD and Helicobacter pylori-related disease, rather than treating every digestive enquiry as an endoscopy request.

Endoscopy and intervention connect several clinical directions, including pancreatobiliary disease and early gastrointestinal neoplasia. Gastrointestinal bleeding is also listed as a clinical focus. Active bleeding requires local urgent assessment rather than waiting for an overseas reply. For a stable, already investigated problem, ask what the receiving team would need to review and what decision the proposed assessment is meant to address.

Named people and the roles the record supports

Tang Chengwei was described in a November 2023 hospital report as the department's academic discipline director, professor, chief physician and doctoral supervisor, and was elected chair of the 12th Chinese Society of Gastroenterology at a meeting that month. These are dated academic roles, rather than confirmation of every current administrative appointment.

Hu Bing was recorded in an August 2025 hospital report as elected vice chair of the 9th Chinese Society of Digestive Endoscopy, and as the hospital's gastroenterology deputy director and director of an endoscopic medical-engineering laboratory. That same report describes leadership of a national key research and development project and work on devices, patents and artificial intelligence agents. A research and engineering profile of this kind does not by itself establish outpatient availability for a particular patient.

Wang Chunhui's official clinical biography describes a professor and doctoral supervisor with a pancreatobiliary and ERCP focus, and contribution to research on translational prevention and treatment of severe acute pancreatitis. Hu Renwei's official profile lists associate chief physician status with a focus on Helicobacter pylori-related disease, inflammatory bowel disease and complex digestive disease, plus working-group and academic-group roles in Sichuan and nationally. None of these profiles should be read as a statement that every named person heads a department or accepts overseas referrals.

Research that shapes the questions patients can ask

The department's research is not decorative. Work described in the hospital's own materials on early gastrointestinal neoplasia and biliary-pancreatic disease includes database and biobank development, pathology and assessment pathways, follow-up, and medical-engineering collaboration. Reports mention research on peroral endoscopic myotomy variants, traction-assisted endoscopic submucosal dissection, and biliary stent research with patented devices in translation.

The distinction between clinical service and research is especially useful when preparing an enquiry. A question about an established bile-duct condition is different from an enquiry about an investigational stent, just as an early-neoplasia assessment is not a request for a particular patented device. State the diagnosis and the unresolved decision, then ask how the relevant clinical group would review the available information.

Research activity does not establish that a device, technique or trial is available to you, nor that it is safer or more effective for your case. Those are questions for the treating clinicians, answered against your own records.

Honours and what they do and do not tell you

Tang Chengwei received the World Gastroenterology Organisation Master honor at its September 2025 congress, as recorded in a hospital report later that month. The recognition concerned digestive-disease innovation and medical education. Her documented honors also include National Distinguished Young Scholar support and the first Guozhimingyi Outstanding Achievement recognition.

Hu Bing's documented recognitions include a Sichuan Science Progress First Prize, a Yunnan Science Progress Special Prize and Tianfu Famous Doctor. Wang Chunhui contributed to severe acute pancreatitis research recognized with a 2014 Sichuan Science Progress First Prize. His biography also records Sichuan and Chinese Medical Second Prizes for a separate preclinical gastric-cancer project. These recognitions concern different people and work, not a single award held by everyone in the department.

Honours describe recognition of research or professional contribution. They are not a prediction of your outcome, and they do not tell you which clinician will be assigned to your care.

Clarifying the scope of a digestive-disease assessment

Specify what another opinion should address: the diagnosis, a previous endoscopic finding, an earlier treatment plan or a continuing management question. Ask which clinical direction would review it and which existing reports should be supplied. A records-based response and an in-person assessment are different steps, so clarify what the hospital proposes before arranging travel.

The department's academic descriptions connect liver disease, pancreatic disease and endoscopic research with different contributors. Tang Chengwei's 2023 academic activity included chronic-pancreatitis epidemiology and immune dysfunction in cirrhosis; Hu Bing's work emphasizes medical-engineering and endoscopic questions; Wang Chunhui's biography emphasizes pancreatobiliary work. These are useful distinctions when explaining the purpose of an enquiry, rather than simply requesting an appointment with the most prominent name.

Preparing a focused endoscopy or specialist enquiry

If another clinician has already suggested an endoscopic procedure, state that proposal and the question on which another opinion is sought. Ask what the receiving team would need before commenting and whether its response would depend on an in-person assessment. The specific procedure, consent discussion and subsequent follow-up arrangements remain matters for the treating clinicians.

ChinaSpecialistCare can help organise a gastroenterology enquiry, prepare records and coordinate visit arrangements after hospital acceptance. We are independent of the hospital and cannot guarantee a named clinician, procedure or outcome. An initial enquiry is free; an optional proxy consultation is not required before asking a preliminary question.

Digestive disease care in China